Related Experiment Videos
[Second set method for determining the immunogenicity of heart valves]
Biulleten' Eksperimental'Noi Biologii I Meditsiny
|October 1, 1983
Summary
Pretreating heart valves with a proteolytic enzyme before glutaric aldehyde fixation significantly reduces immunogenicity. This enzyme pretreatment prevents sensitization and calcification, unlike glutaric aldehyde alone.
Area of Science:
- Biomaterials Science
- Immunology
- Tissue Engineering
Background:
- Heart valve tissue requires effective fixation for transplantation.
- Glutaraldehyde is a common fixative but can cause immunogenic reactions.
- Investigating methods to reduce the immunogenicity of fixed heart valves is crucial for improving transplant outcomes.
Purpose of the Study:
- To evaluate the immunogenicity of heart valves treated with a proteolytic enzyme and glutaric aldehyde.
- To compare this treatment's immunogenicity with valves treated with glutaric aldehyde alone.
- To determine if enzyme pretreatment reduces recipient immune response and tissue calcification.
Main Methods:
- The
- second set
- method was employed using inbred rats.
- Heart valves were treated with a proteolytic enzyme followed by glutaric aldehyde (0.2-0.5%).
- A control group received valves treated with 0.5% glutaric aldehyde alone (Hancock's method).
Main Results:
- Valves treated with enzyme and glutaric aldehyde did not induce body sensitization.
- Valves treated with glutaric aldehyde alone showed signs of immunologic response in recipients.
- Calcification of valvular tissue was observed 70 days post-subcutaneous implantation in the glutaric aldehyde-only group.
Conclusions:
- Pretreatment of heart valves with a proteolytic enzyme can significantly reduce their immunogenicity.
- This enzyme pretreatment appears to prevent the adverse immune responses and calcification seen with glutaric aldehyde fixation alone.
- Enzyme-assisted fixation offers a promising strategy for developing less immunogenic bioprosthetic heart valves.